糖尿病患者向けパーソナライズ自宅食事プラン

家

AIプロンプト一覧

医療健康

糖尿病自宅食事プラン作成

${:__('collect %s',糖尿病自宅食事プラン作成)}$

医療健康

2型糖尿病患者の食事嗜好、血糖値管理目標、常用薬に基づき、中国家庭の食材調達習慣に合った1週間の自宅食事プランを作成し、食事禁忌と血糖値測定リマインダーを記載します。

プロンプト内容

コピー

Based on the dietary preferences provided by a 45-year-old type 2 diabetic who is 168cm tall, weighs 70kg, has a fasting blood glucose of 7.5mmol/L and takes metformin daily, generate a one-week home diet plan that fits Chinese cooking habits, mark the approximate calorie and carbohydrate ratio for each meal, clarify dietary contraindications and corresponding postprandial blood glucose monitoring time reminders, use common and easily purchasable ordinary ingredients, and do not recommend special functional health products.

コピー

身長168cm、体重70kg、空腹時血糖値7.5mmol/Lでメトホルミンを服用中の45歳の2型糖尿病患者が提示した日常の食事嗜好に基づき、中国人の調理習慣に合った1週間の自宅食事プランを作成し、毎食のおおよそのカロリーと炭水化物比率を記載し、食事禁忌と対応する食後血糖値測定の時間リマインダーを明記し、入手しやすい一般的な食材を使用し、特殊な機能性健康食品は推奨しないでください。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方審査アシスタント

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage合理性, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing drug-drug interactions, dosage appropriateness, and allergy contraindications, identifying potential risks, and providing adjustment suggestions to ensure the treatment plan aligns with the latest clinical guidelines.

処方箋審査アシスタント

Act as an intelligent audit assistant for a hospital pharmacy. Perform a deep compliance check on the provided electronic prescription data. First, extract patient demographics, diagnosis, and the list of prescribed medications, focusing on analyzing potential drug-drug interactions, especially for elderly patients or those with hepatic/renal impairment. Second, cross-reference medication contraindications with the patient's medical history and allergies, and identify any off-label usage. Finally, generate a structured audit report that clearly highlights potential risks, recommends safe alternative options or dosage adjustments, and flags items requiring manual pharmacist review, ensuring the prescription adheres to clinical medication guidelines before dispensing.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided electronic prescription for compliance. Focus on analyzing the patient's current medication list for potential drug interactions, contraindication conflicts, or dosages exceeding recommended ranges. If risks are identified, point out specific issues based on the latest clinical guidelines and provide adjustment suggestions; if no anomalies exist, confirm that the prescription meets standard treatment protocols.